
Roundhill GLP-1 & Weight Loss ETF
Roundhill GLP-1 & Weight Loss ETF (OZEM) Price & Chart
OZEM ETF Chart & Stats
- Day’s Range
- $31.23 - $31.65
- 52-Week Range
- $28.34 - $37.15
- Previous Close
- $31.73
- Volume
- 8,098
- Average Volume (3M)
- 13.56K
- AUM
- 58.23M
- NAV
- 31.83
- Expense Ratio
- 0.59%
- Holdings Count
- 26
- Beta
- 0.73
- Inception Date
- May 21, 2024
- Last Dividend Ex-Date
- Dec 30, 2025
- Dividend Yield
- (1.31%)
- Shares Outstanding
- 1,830,000
- Standard Deviation
- N/A
ETF Overview
Roundhill GLP-1 & Weight Loss ETF
The Roundhill GLP-1 & Weight Loss ETF (Ticker: OZEM) is an innovative financial instrument designed to capture the burgeoning opportunities within the healthcare sector, specifically targeting the dynamic realm of pharmaceuticals, biotechnology, and life sciences. This ETF is meticulously crafted for investors seeking to capitalize on the transformative advancements in GLP-1 receptor agonists and weight management solutions. As the global focus shifts increasingly towards health and wellness, OZEM provides exposure to companies at the forefront of developing cutting-edge therapies and technologies aimed at addressing obesity and related metabolic disorders. Its strategic positioning within this niche sector allows investors to gain access to a diversified portfolio of pioneering firms leading the charge in groundbreaking research and development. The Roundhill GLP-1 & Weight Loss ETF not only offers potential growth opportunities but also aligns with the broader societal trend towards healthier living, making it a compelling addition to any forward-thinking investment strategy.
- Asset Class
- Equity
- Region
- Global
- Issuer
- Roundhill
- Index Tracked
- No Underlying Index
- Ticker Symbol
- OZEM
OZEM ETF News


OZEM ETF FAQ
What was OZEM’s price range in the past 12 months?
What is the AUM of OZEM?
Is OZEM overvalued?
Does OZEM pay dividends?
How many shares outstanding does OZEM have?
OZEM ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 15.28% |
| NVONovo Nordisk | 11.65% |
| PFEPfizer Inc | 7.69% |
| KLRAKailera Therapeutics, Inc. | 6.30% |
| 1093CSPC Pharmaceutical Group | 5.36% |
| 4519Chugai Pharmaceutical Co | 5.07% |
| AMGNAmgen Inc | 4.70% |
| VKTXViking Therapeutics | 4.62% |
| 128940KR:128940 | 4.34% |
| AZNAstraZeneca plc | 4.21% |
| Total | 69.22% |












